Home › Funds › Point72 Asset Management › AVTX
Point72 Asset Management position in AVTX
AVALO THERAPEUTICS INC · Health Care
Latest position (Q2 2026)2.39M sh
Reported value held$44.11M
Portfolio Weight0.17%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 6.01M | $13.10M | New |
| Q4 2021 | 6.01M | $10.21M | Hold |
| Q1 2022 | 6.01M | $4.36M | Hold |
| Q2 2022 | 6.01M | $3.00M | Hold |
| Q3 2022 | 500.74K | $1.66M | Reduce |
| Q4 2022 | 500.74K | $2.52M | Hold |
| Q1 2023 | 1.10M | $1.93M | Add |
| Q3 2025 | 1.05M | $13.40M | New |
| Q4 2025 | 627.50K | $11.40M | Reduce |
| Q1 2026 | 916.14K | $13.68M | Add |
| Q2 2026 | 2.39M | $44.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AVTX
- Fidelity Management & Research (FMR) 5.10M sh · $94.25M · Q2 2026
- BlackRock Inc 4.37M sh · $80.68M · Q2 2026
- Deep Track Capital, LP 3.61M sh · $66.71M · Q2 2026
- Caligan Partners LP 3.16M sh · $58.47M · Q2 2026
- TCG Crossover Management, LLC 3.02M sh · $55.76M · Q2 2026
- Affinity Asset Advisors, LLC 2.90M sh · $53.59M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.50M sh · $46.16M · Q2 2026
- Farallon Capital Management 2.50M sh · $46.16M · Q2 2026
- Avoro Capital Advisors LLC 2.33M sh · $43.12M · Q2 2026
- BVF INC/IL 2.08M sh · $38.36M · Q2 2026
- Bank of America Corp 1.91M sh · $35.37M · Q2 2026